Hence, in tumours without PAX3/7-FKHR fusion genes, it is possible that mechanisms other than those associated with PAX3/7-FKHR fusion genes cause increased expression of wild-type PAX genes, with the same tumorigenic outcome as expression of the chimaeric proteins. The gene discussed is FOXO1; the disease is neoplasm.